यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - prašiči - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 12 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 12 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 200 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 200 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 30 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 30 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 6 c / 1 g - -

स्लोवेनिया - स्लोवेनियाई - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

adriapharm d.o.o. - hyoscyamus niger - kroglica - hyoscyamus niger 6 c / 1 g - -

यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

intervet international b.v. - prašičev circovirus tipa 2 (pcv2) orf2 podenote antigen, mikroplazma hyopneumoniae j sev inaktivirano - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - prašičev (za pitanje) - za aktivno imunizacijo prašičev za zmanjšanje viraemia, virus nalagajo v pljučih in lymphoid tkiv, virus prelivanje zaradi prašičev circovirus tipa 2 (pcv2) okužbe, in resnosti pljuč poškodb, ki jih povzročajo mikroplazma hyopneumoniae okužbe. da bi zmanjšali izgubo dnevnega povečanja telesne mase med končnim obdobjem ob okužbah z mycoplasmo hyopneumoniae in / ali pcv2 (kot je bilo ugotovljeno v terenskih študijah).